Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.

about

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation.

P2860

Q55040697-EF20A251-4349-44E2-B14C-631B0C3232E8

P2860

Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.

Item

http://www.wikidata.org/entity/Q50502365

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@en

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@nl

type

Item

label

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@en

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@nl

prefLabel

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@en

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@nl

P1476

Efficacy and Safety of Adjuvan ...... n: A Systematic Meta-Analysis.

@en

P2093

Jia Li

http://www.w3.org/2001/XMLSchema#string

Jiajun Chen

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Liu

http://www.w3.org/2001/XMLSchema#string

Yajuan Sun

http://www.w3.org/2001/XMLSchema#string

Zhiwei Lou

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.

A systematic review of catechol-0-methyltransferase inhibitors: efficacy and safety in clinical practice.

Levodopa and the progression of Parkinson's disease.

Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease.

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

Clinical advantages of COMT inhibition with entacapone - a review.

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.

P304

143-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1159/000479555

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28813703

http://www.w3.org/2001/XMLSchema#string

Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.

about

P2860

P2860

Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698